Read On Any Languages

Saturday, 10 June 2017

loobobilly News: FDA Asks Drug Maker To Pull Opioid Opana ER Off The Market

FDA Asks Drug Maker To Pull Opioid Opana ER Off The Market The Food and Drug Administration requested drug maker Endo Pharmaceuticals stop selling Opana ER, which is an opioid. NPR's Robert Siegel speaks with Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, about the decision. The Food and Drug Administration requested drug maker Endo Pharmaceuticals stop selling Opana ER, which is an opioid. NPR's Robert Siegel speaks with Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, about the decision. Business
The Food and Drug Administration requested drug maker Endo Pharmaceuticals stop selling Opana ER, which is an opioid. NPR's Robert Siegel speaks with Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, about the decision.

Read more on NPR
Icon Icon Icon Follow Me on Google Plus Follow Me on Pinterest

Copyright 2014 All Rights Reserved / Privacy Policy / Sitemap / Contact Us

Edited by / loobobilly / Powered by / M.S.Aditya